Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program

PURPOSE: Among metastatic breast cancer (MBC) patients, those with a triple-negative breast cancer phenotype (mTNBC) have the worst prognosis, but the benefit of chemotherapy beyond second line on outcome remains uncertain. The purpose of this study was to identify predictive factors of outcome afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabel, Luc, Carton, Matthieu, Pistilli, Barbara, Dalenc, Florence, Vanlemnens, Laurence, Levy, Christelle, Jacot, William, Debled, Michel, Loeb, Agnes, Hennequin, Audrey, De la Motte Rouge, Thibault, Laborde, Lilian, Laurent, Carine, Chamorey, E., Parent, Damien, Petit, Thierry, Mouret-Reynier, Marie-Ange, Campone, Mario, Perrocheau, Geneviève, Labreveux, Claire, Bachelot, Thomas, Robain, Mathieu, Lerebours, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873471/
https://www.ncbi.nlm.nih.gov/pubmed/33561617
http://dx.doi.org/10.1016/j.breast.2021.01.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873471/
https://www.ncbi.nlm.nih.gov/pubmed/33561617
http://dx.doi.org/10.1016/j.breast.2021.01.006

Ejemplares similares